Detailansicht

Wissensnetz

Person

Peter Hass (1966-)

Arzt

Name	Peter Hass
Zeit	1966- (Lebensdaten)
Ort	Köthen (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	PD Dr. med.
Beruf	Arzt (charakteristischer Beruf) Radiologe
Beziehung	Humanmedizin (Studienfach)
Weitere Angaben	Promotion am Fachbereich Humanmedizin an der Universität Magdeburg 1997; 2006-01-05 to present, Otto-von-Guericke-Universität Magdeburg · Medizinische Fakultät · Universitätsklinik für Strahlentherapie
Datensatztyp	Person
GND-Nummer	120234289
Datensatz-ID	120234289
Beteiligt an alle anzeigen Neoadjuvant radiochemotherapy with cisplatin/5-flourouracil or carboplatin/paclitaxel in patients with resectable cancer of the esophagus and the gastroesophageal junction — comparison of postoperative mortality and complications, toxicity, and pathological tumor response Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model Interstitial brachytherapy for hepatocellular carcinoma : Analysis of prognostic factors for overall survival and progression-free survival and application of a risk stratification model Stellenwert der High-Dose-Rate- (HDR-) Brachytherapie innerhalb interdisziplinärer onkologischer Konzepte A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer Feasibility of MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: ProFocAL-study Can alternative liver function scores facilitate the establishment of an indication for radioablative therapy in patients with hepatocellular carcinoma? Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145 Multimodale Therapie primärer, nicht metastasierter retroperitonealer Sarkome Efficacy and toxicity of different chemotherapy protocols for concurrent chemoradiation in non-small cell lung cancer - a secondary analysis of the PET plan trial MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL) Ultrasound-assisted catheter placement in CT-guided HDR brachytherapy for the local ablation of abdominal malignancies: Initial experience Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival Strahlentherapie bei hepatozellulärem Karzinom Vaginal brachytherapy for endometrial cancer Combined Systemic Chemotherapy and CT-Guided High-Dose-Rate Brachytherapy for Isolated Local Manifestation of Pancreatic Cancer after Surgical Resection Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease Haemorrhagic Complications and Symptomatic Venous Thromboembolism in Interventional Tumour Ablations: The Impact of Peri-interventional Thrombosis Prophylaxis Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factors Bayesian cure rate modeling of local tumor control: evaluation in stereotactic body radiation therapy for pulmonary metastases Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy" Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study) Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization) CT-gesteuerte Brachytherapie Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy Die protektive Wirkung von subcutan appliziertem Magnesiumsulfat gegenüber exzitotoxischer Schädigung des Hippocampus der Ratte

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Peter Hass (1966-)

Neoadjuvant radiochemotherapy with cisplatin/5-flourouracil or carboplatin/paclitaxel in patients with resectable cancer of the esophagus and the gastroesophageal junction — comparison of postoperative mortality and complications, toxicity, and pathological tumor response

Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial

Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model

Interstitial brachytherapy for hepatocellular carcinoma : Analysis of prognostic factors for overall survival and progression-free survival and application of a risk stratification model

Stellenwert der High-Dose-Rate- (HDR-) Brachytherapie innerhalb interdisziplinärer onkologischer Konzepte

A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer

Feasibility of MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: ProFocAL-study

Can alternative liver function scores facilitate the establishment of an indication for radioablative therapy in patients with hepatocellular carcinoma?

Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145

Multimodale Therapie primärer, nicht metastasierter retroperitonealer Sarkome

Efficacy and toxicity of different chemotherapy protocols for concurrent chemoradiation in non-small cell lung cancer - a secondary analysis of the PET plan trial

MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL)

Ultrasound-assisted catheter placement in CT-guided HDR brachytherapy for the local ablation of abdominal malignancies: Initial experience

Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT

Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial

Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival

Strahlentherapie bei hepatozellulärem Karzinom

Vaginal brachytherapy for endometrial cancer

Combined Systemic Chemotherapy and CT-Guided High-Dose-Rate Brachytherapy for Isolated Local Manifestation of Pancreatic Cancer after Surgical Resection

Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma

Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements

Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer

Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study

Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease

Haemorrhagic Complications and Symptomatic Venous Thromboembolism in Interventional Tumour Ablations: The Impact of Peri-interventional Thrombosis Prophylaxis

Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : Complications and risk factors

Bayesian cure rate modeling of local tumor control: evaluation in stereotactic body radiation therapy for pulmonary metastases

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)

CT-gesteuerte Brachytherapie

Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy

Die protektive Wirkung von subcutan appliziertem Magnesiumsulfat gegenüber exzitotoxischer Schädigung des Hippocampus der Ratte